Patient Centered Research Subcategories
Adherence, Persistence, & Compliance
-
Checklist for Medication Compliance and Persistence Studies Using Retrospective Databases
-
Understanding Medication Compliance and Persistence from an Economics Perspective
-
Medication Compliance and Persistence: Terminology and Definitions
-
Costs of Medication Non adherence in Patients with Diabetes Mellitus: A Systematic Review and Critical Analysis of the Literature
-
Impact of Interventions on Medication Adherence and Blood Pressure Control in Patients with Essential Hypertension: A Systematic Review by the ISPOR Medication Adherence and Persistence Special Interest Group
-
Systematic Literature Review of Psychosocial and Behavioral Factors Associated with Initial Medication Adherence
-
Initial Medication Adherence - Review and Recommendations for Good Practices in Outcomes Research: An ISPOR Medication Adherence and Persistence Special Interest Group Report
-
Methods for Measuring Multiple Medication Adherence: A Systematic Review
-
Methods for Integrating Medication Compliance and Persistence in Pharmacoeconomic Evaluations
Health State Utilities
Patient Engagement
Patient-Reported Outcomes & Quality of Life Outcomes
-
Updated Recommendations on Evidence Needed to Support Measurement Comparability Among Modes of Data Collection for Patient-Reported Outcome Measures
-
Patient-Reported Outcome and Observer-Reported Outcome Assessment in Rare Disease Clinical Trials
-
PRO Data Collection in Clinical Trials Using Mixed Modes
-
Pediatric Patient-Reported Outcome Instruments for Research to Support Medical Product Labeling
-
Validation of Electronic Systems to Collect Patient-Reported Outcome (PRO) Data - Recommendations for Clinical Trial Teams
-
Content Validity - Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation Part 1
-
Content Validity – Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation Part 2
-
Use of Existing Patient-Reported Outcome (PRO) Instruments and Their Modification
-
Multinational Trials – Recommendations on the Translations Required, Approaches to Using the Same Language in Different Countries, and the Approaches to Support Pooling the Data
-
Recommendations on Evidence Needed to Support Measurement Equivalence between Electronic and Paper-Based Patient-Reported Outcome (PRO) Measures
-
Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures
Stated Preference & Patient Satisfaction
-
Quantitative Benefit-Risk Assessment in Medical Product Decision Making
-
A Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health
-
Accounting For Preference Heterogeneity In Discrete-Choice Experiments
-
Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions - Report of the ISPOR Stated Preference Research Special Interest Group
-
Statistical Methods for the Analysis of Discrete-Choice Experiments
-
Multiple Criteria Decision Analysis for Health Care Decision Making - An Introduction: Report 1
-
Multiple Criteria Decision Analysis for Health Care Decision Making - Emerging Good Practices: Report 2
-
Constructing Experimental Designs for Discrete-Choice Experiments
-
Conjoint Analysis Applications in Health - A Checklist
All Patient-Centered Research Reports
Please Note: Reports are in reverse chronological order.
-
Updated Recommendations on Evidence Needed to Support Measurement Comparability Among Modes of Data Collection for Patient-Reported Outcome Measures
-
Quantitative Benefit-Risk Assessment in Medical Product Decision Making
-
A Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health
-
Accounting For Preference Heterogeneity In Discrete-Choice Experiments
-
Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions - Report of the ISPOR Stated Preference Research Special Interest Group
-
Defining Patient Engagement in Research: Results of a Systematic Review and Analysis
-
Checklist for Medication Compliance and Persistence Studies Using Retrospective Databases
-
Understanding Medication Compliance and Persistence from an Economics Perspective
-
Medication Compliance and Persistence: Terminology and Definitions
-
Costs of Medication Non adherence in Patients with Diabetes Mellitus: A Systematic Review and Critical Analysis of the Literature
-
Impact of Interventions on Medication Adherence and Blood Pressure Control in Patients with Essential Hypertension: A Systematic Review by the ISPOR Medication Adherence and Persistence Special Interest Group
-
Systematic Literature Review of Psychosocial and Behavioral Factors Associated with Initial Medication Adherence
-
Initial Medication Adherence - Review and Recommendations for Good Practices in Outcomes Research: An ISPOR Medication Adherence and Persistence Special Interest Group Report
-
Methods for Measuring Multiple Medication Adherence: A Systematic Review
-
Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models
-
Patient-Reported Outcome and Observer-Reported Outcome Assessment in Rare Disease Clinical Trials
-
Mapping to Estimate Health-State Utility from Non-Preference-Based Outcome Measures
-
Estimating Health-State Utility for Economic Models in Clinical Studies
-
Statistical Methods for the Analysis of Discrete-Choice Experiments
-
Multiple Criteria Decision Analysis for Health Care Decision Making - An Introduction: Report 1
-
Multiple Criteria Decision Analysis for Health Care Decision Making - Emerging Good Practices: Report 2
-
PRO Data Collection in Clinical Trials Using Mixed Modes
-
Pediatric Patient-Reported Outcome Instruments for Research to Support Medical Product Labeling
-
Validation of Electronic Systems to Collect Patient-Reported Outcome (PRO) Data - Recommendations for Clinical Trial Teams
-
Constructing Experimental Designs for Discrete-Choice Experiments
-
Content Validity - Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation Part 1
-
Content Validity – Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation Part 2
-
Conjoint Analysis Applications in Health - A Checklist
-
Use of Existing Patient-Reported Outcome (PRO) Instruments and Their Modification
-
Multinational Trials – Recommendations on the Translations Required, Approaches to Using the Same Language in Different Countries, and the Approaches to Support Pooling the Data
-
Recommendations on Evidence Needed to Support Measurement Equivalence between Electronic and Paper-Based Patient-Reported Outcome (PRO) Measures
-
Methods for Integrating Medication Compliance and Persistence in Pharmacoeconomic Evaluations
-
Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures